Group 2 allergen specific ige-fabs and igg molecules and use...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/16 (2006.01) A61K 39/36 (2006.01) A61K 39/395 (2006.01) G01N 33/563 (2006.01) G01N 33/564 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2429636

The present invention relates to group 2 allergen specific IgE-Fabs and whole Ig molecules as well as use thereof. More precisely, the present invention relates to grass pollen specific IgE-Fabs (Phl p2) and reagents, kits and vaccines comprising these. The invention also relates to use of group 2 specific IgE-Fabs and whole Ig for, inter alia, diagnosis, therapy and prevention of type I allergy.

La présente invention concerne l'immunoglobuline IgE-Fabs spécifique aux allergènes du groupe 2, des molécules Ig entières ainsi que leur utilisation. La présente invention concerne plus précisément l'immunoglobuline IgE-Fabs (Phl p2) spécifique au pollen des plantes herbacées et les réactifs, kits et vaccins les contenant. L'invention concerne également l'utilisation de l'immunoglobuline IgE-Fabs spécifique au groupe 2, et une immunoglobuline entière permettant notamment de diagnostiquer, traitrer et prévenir l'allergie de type I.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Group 2 allergen specific ige-fabs and igg molecules and use... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Group 2 allergen specific ige-fabs and igg molecules and use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Group 2 allergen specific ige-fabs and igg molecules and use... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1405609

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.